NCT01924260 - Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 9, 2013

Primary Completion Date

February 8, 2017

Study Completion Date

February 8, 2017

Conditions

Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic CancerStage IV Pancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

alisertib

Given PO

DRUG

gemcitabine

Given IV

Trial Locations (1)

95817

UC Davis Comprehensive Cancer Center, Sacramento